Seaport Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to advancing a pipeline of transformative medicines for neuropsychiatric disorders. The company utilizes its proprietary Glyph platform, a specialized drug-delivery technology designed to leverage the body’s natural lymphatic transport system. This approach allows for the oral administration of therapeutics that would otherwise be limited by poor absorption or significant first-pass metabolism in the liver, potentially reducing side effects and enhancing therapeutic reach to the brain. Seaport’s clinical pipeline is focused on addressing significant unmet needs in mental health. Its lead candidates include SPT-300, an oral prodrug of allopregnanolone being developed for the treatment of major depressive disorder (MDD) with postpartum depression; SPT-320, an oral prodrug of agomelatine intended for generalized anxiety disorder (GAD); and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen being developed for various neuropsychiatric conditions. Founded by PureTech Health and led by an experienced management team with a track record in CNS drug development, Seaport Therapeutics aims to redefine the treatment landscape for depression, anxiety, and other neurological conditions by optimizing the pharmacological profiles of proven molecules through innovative lymphatic targeting.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!